Literature DB >> 23109983

Hyaline vascular castleman disease involving renal parenchyma and a lymph node: a case report.

Ji Hyun Kwon1, Soo Kee Min, Mi Kyung Shin, Yong Seong Lee, Young-Goo Lee, Young Hyeh Ko.   

Abstract

Castleman disease is a rare lymphoproliferative lesion that is predominantly found in the mediastinum. Retroperitoneal and pararenal localizations are very rare. We describe a 36-year-old man with a hyaline vascular type of Castleman disease involving renal parenchyma and a paraaortic lymph node. Most reported renal Castleman disease was plasma cell type with systemic symptoms. Herein, we report the first Korean case of the hyaline vascular type of Castleman disease involving the renal parenchyma and the paraaortic lymph node simultaneously.

Entities:  

Keywords:  Giant lymph node hyperplasia; Hyaline vascular type, Multicentric; Kidney

Year:  2012        PMID: 23109983      PMCID: PMC3479711          DOI: 10.4132/KoreanJPathol.2012.46.1.79

Source DB:  PubMed          Journal:  Korean J Pathol        ISSN: 1738-1843


  12 in total

1.  HHV-8 infection status of AIDS-unrelated and AIDS-associated multicentric Castleman's disease.

Authors:  T Suda; H Katano; G Delsol; C Kakiuchi; T Nakamura; M Shiota; T Sata; M Higashihara; S Mori
Journal:  Pathol Int       Date:  2001-09       Impact factor: 2.534

2.  Localized mediastinal lymphnode hyperplasia resembling thymoma.

Authors:  B CASTLEMAN; L IVERSON; V P MENENDEZ
Journal:  Cancer       Date:  1956 Jul-Aug       Impact factor: 6.860

3.  [Hyaline vascular type of Castleman's disease confined to the kidney].

Authors:  Tomoyuki Kaneko; Tetsuo Ogushi; Yasuyuki Asakage; Tadaichi Kitamura
Journal:  Nihon Hinyokika Gakkai Zasshi       Date:  2008-05

4.  Castleman disease of the hyaline-vascular type confined to the kidney.

Authors:  Nicole A Mah; Samuel J Peretsman; Chris M Teigland; Peter M Banks
Journal:  Am J Clin Pathol       Date:  2007-03       Impact factor: 2.493

5.  Pathogenic significance of interleukin-6 (IL-6/BSF-2) in Castleman's disease.

Authors:  K Yoshizaki; T Matsuda; N Nishimoto; T Kuritani; L Taeho; K Aozasa; T Nakahata; H Kawai; H Tagoh; T Komori
Journal:  Blood       Date:  1989-09       Impact factor: 22.113

Review 6.  Multicentric Castleman's disease.

Authors:  B A Peterson; G Frizzera
Journal:  Semin Oncol       Date:  1993-12       Impact factor: 4.929

7.  A systemic lymphoproliferative disorder with morphologic features of Castleman's disease. Pathological findings in 15 patients.

Authors:  G Frizzera; P M Banks; G Massarelli; J Rosai
Journal:  Am J Surg Pathol       Date:  1983-04       Impact factor: 6.394

8.  Hyaline vascular Castleman's disease with HMGIC rearrangement in follicular dendritic cells: molecular evidence of mesenchymal tumorigenesis.

Authors:  K Cokelaere; M Debiec-Rychter; C De Wolf-Peeters; A Hagemeijer; R Sciot
Journal:  Am J Surg Pathol       Date:  2002-05       Impact factor: 6.394

9.  Clinical implications of idiopathic multicentric castleman disease among Japanese: a report of 28 cases.

Authors:  Masaru Kojima; Naoya Nakamura; Norihumi Tsukamoto; Yoshiro Otuski; Kazuhiko Shimizu; Hideaki Itoh; Satsuki Kobayashi; Hiroshi Kobayashi; Takuhei Murase; Nobuhide Masawa; Makoto Kashimura; Shigeo Nakamura
Journal:  Int J Surg Pathol       Date:  2008-05-21       Impact factor: 1.271

Review 10.  Clinicopathologic study of Castleman's disease in Korea.

Authors:  J E Kim; C J Kim; I A Park; W H Kim; J W Seo; J J Jang; C W Kim; S H Park; H S Lee; J G Chi; Y I Kim; E K Ham
Journal:  J Korean Med Sci       Date:  2000-08       Impact factor: 2.153

View more
  2 in total

1.  Laparoscopic treatment for retroperitoneal hyaline-vascular type localized Castleman's disease (LCD) in the iliac vessel region.

Authors:  Aiwen Le; Lili Shan; Zhonghai Wang; Xiaoyun Dai; Tianhui Xiao; Rong Zhuo; Rui Yuan
Journal:  Int J Clin Exp Med       Date:  2015-11-15

Review 2.  Primary hyaline vascular Castleman disease of the kidney: case report and literature review.

Authors:  Yunzhu Li; Haixia Zhao; Bingyin Su; Chan Yang; Shurong Li; Wanlei Fu
Journal:  Diagn Pathol       Date:  2019-08-22       Impact factor: 2.644

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.